Back to Journals » Stem Cells and Cloning: Advances and Applications » Volume 1

Epigenetic modifications of embryonic stem cells: current trends and relevance in developing regenerative medicine

Authors Chung H, Sidhu KS

Published 17 November 2008 Volume 2008:1 Pages 11—21


Review by Single anonymous peer review

Peer reviewer comments 5

Henry Chung, Kuldip S Sidhu

Stem Cell Lab, Faculty of Medicine, School of Psychiatry, University of New South Wales, Sydney, NSW, Australia

Abstract: Epigenetics is a growing field not only in the area of cancer research but recently in stem cells including human embryonic stem cell (hESC) research. The hallmark of profiling epigenetic changes in stem cells lies in maintaining pluripotency or multipotency and in attaining lineage specifications that are relevant for regenerative medicine. Epigenetic modifications including DNA methylation, histone acetylation and methylation, play important roles in regulating gene expressions. Other epigenetic modifications include X chromosome silencing, genomic stability and imprinting and mammalian development. This review attempts to elucidate the mechanism(s) behind epigenetic modifications and review techniques scientists use for identifying each modification. We also discuss some of the trends of epigenetic modifications in the fields of directed differentiation of embryonic stem cells and de-differentiation of somatic cells.

Keywords: epigenetics, embryonic stem cell, somatic cell nuclear transfer, DNA methylation, chromatin modifications

Creative Commons License © 2008 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.